Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology

被引:0
|
作者
Carlos M. Ferrario
机构
[1] Wake Forest University Health Science Center,Hypertension and Vascular Disease Center
来源
Current Hypertension Reports | 2003年 / 5卷
关键词
Angiotensin; Angiotensin Converting Enzyme; Losartan; Bradykinin; Neutral Endopeptidase;
D O I
暂无
中图分类号
学科分类号
摘要
Increased understanding of the contribution of angiotensin peptides to the physiologic control of arterial pressure and cardiovascular regulation has been made possible with the introduction of agents that either inhibit the activity of angiotensins forming enzymes or block the action of the peptides at their specific receptor subtypes. This review highlights some of the lessons that have been learned from the study of the actions of angiotensin-(1-7) and its interrelationship with other vasodilator mechanisms that modulate the control systems that determine blood pressure and tissue perfusion. The studies suggest that the reninangiotensin system acts as a humoral mechanism for blood pressure control through the generation of several distinct forms of angiotensin peptides that may bind to diverse receptor subtypes.
引用
收藏
页码:129 / 134
页数:5
相关论文
共 50 条
  • [21] Therapeutic uses for Angiotensin-(1-7)
    Machado-Silva, Alice
    Passos-Silva, Danielle
    Santos, Robson Augusto
    Sinisterra, Ruben Dario
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2016, 26 (06) : 669 - 678
  • [22] [7-D-ALA]-ANGIOTENSIN-(1-7) - SELECTIVE ANTAGONISM OF ANGIOTENSIN-(1-7) IN THE RAT PARAVENTRICULAR NUCLEUS
    AMBUHL, P
    FELIX, D
    KHOSLA, MC
    BRAIN RESEARCH BULLETIN, 1994, 35 (04) : 289 - 291
  • [23] Hypothalamic cardiovascular effects of angiotensin-(1-7) in spontaneously hypertensive rats
    Hocht, Christian
    Opezzo, Javier A. W.
    Gironacci, Mariela M.
    Pena, Clara
    Taira, Carlos A.
    REGULATORY PEPTIDES, 2006, 135 (1-2) : 39 - 44
  • [24] CHARACTERIZATION OF A NEW ANGIOTENSIN ANTAGONIST SELECTIVE FOR ANGIOTENSIN-(1-7) - EVIDENCE THAT THE ACTIONS OF ANGIOTENSIN-(1-7) ARE MEDIATED BY SPECIFIC ANGIOTENSIN RECEPTORS
    SANTOS, RAS
    CAMPAGNOLESANTOS, MJ
    BARACHO, NCV
    FONTES, MAP
    SILVA, LCS
    NEVES, LAA
    OLIVEIRA, DR
    CALIGIORNE, SM
    RODRIGUES, ARV
    GROPEN, C
    CARVALHO, WS
    SILVA, ACSE
    KHOSLA, MC
    BRAIN RESEARCH BULLETIN, 1994, 35 (04) : 293 - 298
  • [25] Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy
    Schindler, Christoph
    Bramlage, Peter
    Kirch, Wilhelm
    Ferrario, Carlos M.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2007, 3 (01) : 125 - 137
  • [26] Analysis of the role of angiotensin-(1-7) in the regulation of cardiovascular responses in the rat
    Master, RG
    Greco, AJ
    Baber, SR
    Kadowitz, PJ
    FASEB JOURNAL, 2005, 19 (05): : A1559 - A1560
  • [27] Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats
    Widdop, RE
    Sampey, DB
    Jarrott, B
    HYPERTENSION, 1999, 34 (04) : 964 - 968
  • [28] Angiotensin-(1-7): A novel therapeutic target for preventing cardiovascular disease
    Kumar, Gupta Jeetendra
    Krishanveer, Singh
    Kuldeep, Singh
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2022, 17 (07): : 134 - 143
  • [29] Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction
    Benter, Ibrahim F.
    Yousif, Mariam H. M.
    Cojocel, Constantin
    Al-Maghrebi, May
    Diz, Debra I.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (01): : H666 - H672
  • [30] Alamandine but not angiotensin-(1-7) produces cardiovascular effects in the Insular Cortex
    Marins, Fernanda R.
    Oliveira, Aline C.
    Qadri, Fatimunnisa
    Alenina, Natalia
    Bader, Michael
    Fontes, Marco A.
    Santos, Robson A.
    HYPERTENSION, 2014, 64